Switch theme
Sign up to access all valuation multiples
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
2002
148
LTM Revenue $65.9M
LTM EBITDA $12.8M
$141M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Pro-Dex has a last 12-month revenue (LTM) of $65.9M and a last 12-month EBITDA of $12.8M.
In the most recent fiscal year, Pro-Dex achieved revenue of $53.8M and an EBITDA of $4.4M.
Pro-Dex expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Pro-Dex valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $65.9M | XXX | $53.8M | XXX | XXX | XXX |
| Gross Profit | $20.8M | XXX | $14.6M | XXX | XXX | XXX |
| Gross Margin | 32% | XXX | 27% | XXX | XXX | XXX |
| EBITDA | $12.8M | XXX | $4.4M | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 8% | XXX | XXX | XXX |
| EBIT | $11.1M | XXX | $7.2M | XXX | XXX | XXX |
| EBIT Margin | 17% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $8.8M | XXX | $2.1M | XXX | XXX | XXX |
| Net Margin | 13% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $9.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Pro-Dex's stock price is $40.
Pro-Dex has current market cap of $132M, and EV of $141M.
See Pro-Dex trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $141M | $132M | XXX | XXX | XXX | XXX | $2.63 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Pro-Dex has market cap of $132M and EV of $141M.
Pro-Dex's trades at 2.3x EV/Revenue multiple, and 16.1x EV/EBITDA.
Equity research analysts estimate Pro-Dex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pro-Dex has a P/E ratio of 15.0x.
See valuation multiples for Pro-Dex and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $132M | XXX | $132M | XXX | XXX | XXX |
| EV (current) | $141M | XXX | $141M | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | 11.0x | XXX | 16.1x | XXX | XXX | XXX |
| EV/EBIT | 12.6x | XXX | 15.1x | XXX | XXX | XXX |
| EV/Gross Profit | 6.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 15.0x | XXX | 22.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 29.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPro-Dex's last 12 month revenue growth is 6%
Pro-Dex's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $50K for the same period.
Pro-Dex's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pro-Dex's rule of X is 34% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Pro-Dex and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | -1% | XXX | 31% | XXX | XXX | XXX |
| Rule of 40 | 21% | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 34% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $50K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pro-Dex acquired XXX companies to date.
Last acquisition by Pro-Dex was XXXXXXXX, XXXXX XXXXX XXXXXX . Pro-Dex acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Pro-Dex founded? | Pro-Dex was founded in 2002. |
| Where is Pro-Dex headquartered? | Pro-Dex is headquartered in United States of America. |
| How many employees does Pro-Dex have? | As of today, Pro-Dex has 148 employees. |
| Who is the CEO of Pro-Dex? | Pro-Dex's CEO is Mr. Richard L. Van Kirk. |
| Is Pro-Dex publicy listed? | Yes, Pro-Dex is a public company listed on NAS. |
| What is the stock symbol of Pro-Dex? | Pro-Dex trades under PDEX ticker. |
| When did Pro-Dex go public? | Pro-Dex went public in 1986. |
| Who are competitors of Pro-Dex? | Similar companies to Pro-Dex include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Pro-Dex? | Pro-Dex's current market cap is $132M |
| What is the current revenue of Pro-Dex? | Pro-Dex's last 12 months revenue is $65.9M. |
| What is the current revenue growth of Pro-Dex? | Pro-Dex revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Pro-Dex? | Current revenue multiple of Pro-Dex is 2.1x. |
| Is Pro-Dex profitable? | Yes, Pro-Dex is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Pro-Dex? | Pro-Dex's last 12 months EBITDA is $12.8M. |
| What is Pro-Dex's EBITDA margin? | Pro-Dex's last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of Pro-Dex? | Current EBITDA multiple of Pro-Dex is 11.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
